<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR11">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pronker</surname>
    <given-names>ES</given-names>
   </name>
   <name>
    <surname>Weenen</surname>
    <given-names>TC</given-names>
   </name>
   <name>
    <surname>Commandeur</surname>
    <given-names>HR</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>AD</given-names>
   </name>
   <name>
    <surname>Claassen</surname>
    <given-names>HJ</given-names>
   </name>
  </person-group>
  <article-title>The gold industry standard for risk and cost of drug and vaccine development revisited</article-title>
  <source>Vaccine</source>
  <year>2011</year>
  <volume>29</volume>
  <fpage>5846</fpage>
  <lpage>5849</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.051</pub-id>
  <pub-id pub-id-type="pmid">21722688</pub-id>
 </element-citation>
</ref>
